Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
03/2014
03/26/2014CN103664793A Azilsartan intermediate and preparation method thereof
03/26/2014CN103664792A Azilsartan intermediate and preparation method thereof
03/26/2014CN103664791A Derivative of 1-acyl benzimidazolone and use thereof as agricultural fungicide
03/26/2014CN103664787A Alkyne heteraromatic ring compound and application thereof
03/26/2014CN103664749A Condensed-cyclic compound and organic light-emitting diode including the condensed-cyclic compound
03/26/2014CN103664646A Novel organic electroluminescent compounds and organic electroluminescent device using the same
03/26/2014CN102887836B L-phenylglycine derivative and application thereof
03/25/2014US8680274 Bent allenes, and their metal complexes
03/25/2014CA2717579C Alkylated benzimidazolone compounds and self-assembled nanostructures thereof
03/25/2014CA2585983C Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases
03/25/2014CA2547020C 1h-imidazo[4,5-c]pyridine-4-amine derivatives as immune response modifier
03/20/2014WO2014043246A1 Enoyl reductase inhibitors with antibacterial activity
03/20/2014US20140080879 Factor viia inhibitor
03/20/2014US20140080876 Antimicrobial and radioprotective compounds
03/20/2014US20140080828 Imidazolyl amide compounds and uses related thereto
03/20/2014US20140077175 Condensed-cyclic compound and organic light-emitting diode including the condensed-cyclic compound
03/20/2014US20140076036 Dabigatran etexilate and related substances, processes and compositions, and use of the substances as reference standards and markers
03/19/2014EP2707360A1 Dabigatran etexilate and related substances, processes and compositions, and use of the substances as reference standards and markers
03/18/2014US8674113 Compounds
03/13/2014WO2014038663A1 Method for producing sulfonyl amidine compound
03/13/2014WO2014037340A1 Use of substituted 2-amidobenzimidazoles, 2-amidobenzoxazoles and 2-amidobenzothiazoles or salts thereof as active substances against abiotic plant stress
03/13/2014US20140073639 Inhibition of antimicrobial targets with reduced potential for resistance
03/12/2014CN103635464A Polyphenylene host compounds
03/12/2014CN103626707A Synthetic method of 2-mercaptobenzimidazole allyl sulfide
03/12/2014CN102558150B Synthesis process for sulfoxide substituted compound
03/12/2014CN101935303B Broadspectrum substituted benzimidazole sulfonamide HIV protease inhibitors
03/11/2014US8669279 Solid forms of bendamustine hydrochloride
03/11/2014US8669114 Hydrophobic ionic liquids
03/06/2014WO2014035860A1 Inhibitors of beta-secretase
03/06/2014US20140066629 Process for the preparation of aromatic azole compounds
03/06/2014US20140066466 Necroptosis Inhibitors and Methods of Use Therefor
03/06/2014US20140066454 Antibiotic Tolerance Inhibitors
03/06/2014US20140066419 Hydroxamic acid derivatives
03/05/2014CN103620808A Organic electroluminescent element
03/05/2014CN102388026B Dichloropropene compounds and uses thereof
02/2014
02/27/2014WO2014031784A1 Compounds for the treatment of paramoxyvirus viral infections
02/27/2014US20140057927 Inhibitors of beta-secretase
02/27/2014US20140057923 Treating Sexual Desire Disorders with Flibanserin
02/26/2014EP2700946A1 Bisubstrate fluorescent probes for protein kinase CK2
02/26/2014CN103601685A Preparation method of oxibendazole
02/26/2014CN103601684A 5-arylselenobenzimidazole compound and application thereof
02/26/2014CN103601683A Benzohetercyclic compounds, preparation method thereof and applications thereof
02/26/2014CN102351799B Bendamustine hydrochloride crystal and preparation method thereof
02/26/2014CN102219746B Preparation method of telmisartan impurity B
02/26/2014CN102212034B Method for preparing telmisartan impurity B
02/25/2014US8658635 Benzpyrazol derivatives as inhibitors of PI3 kinases
02/25/2014US8658207 Extended release tablet formulations of flibanserin and method for manufacturing the same
02/25/2014CA2469953C Imidazo [2,1-.beta.]-1,3,4-thiadiazole sulfonamides
02/20/2014WO2014027280A1 One pot process for the preparation of telmisartan
02/20/2014WO2014027053A1 Benzimidazoles for the treatment of cancer
02/20/2014WO2009021750A3 Benzoxazole, benzimidazole and benzothiazole derivatives and their use in the treatment of duchenne muscular dytrophy
02/19/2014EP2698367A1 Benzimidazoles for the treatment of cancer
02/19/2014CN101405884B Method for preparing doped organic semiconductor materials and formulation utilized therein
02/18/2014US8653259 Process for synthesizing heterocyclic compounds
02/18/2014CA2540459C Benzimidazole compounds and uses in treating proliferative disorders
02/13/2014WO2014026009A2 Inhibition of antimicrobial targets with reduced potential for resistance
02/13/2014WO2014024844A1 Crystals containing unsaturated carboxylic acid amide compound and method for producing same
02/13/2014WO2014024843A1 Crystal containing unsaturated carboxylic acid amide compound and method for producing same
02/13/2014WO2014024687A1 Novel fused polycyclic compound and organic light-emitting device, display apparatus, image information processing apparatus, lighting system, and image forming apparatus having the compound
02/13/2014US20140045909 Denibulin di-hydrochloride
02/12/2014EP2694482A1 Wnt pathway antagonists
02/12/2014CN103582632A 取代的苯并咪唑 Substituted benzimidazoles
02/12/2014CN103579528A Electronic transfer layer, organic light-emitting device comprising electronic transfer layer and manufacturing method of organic light-emitting device
02/12/2014CN103570683A Multi-substituted amine compound, as well as preparation method and use thereof
02/12/2014CN103570625A N-(3-aryl-heteroaryl)-4-aryl-aryl carboxamide and analog as hedgehog pathway inhibitors and application thereof
02/11/2014US8648193 Dinitroxide-type biradical compounds optimized for dynamic nuclear polarization (DNP)
02/11/2014CA2685215C Compounds and methods useful for treating asthma and allergic inflammation
02/11/2014CA2632310C Improved process for the preparation of the salts of 4-(benzimidazolylmethylamino)-benzamides
02/11/2014CA2288330C Benzoyl amino acid derivatives useful as inhibitors of protein isoprenyl tranferases
02/06/2014US20140039022 Manufacture, compositions and uses of coagulation factor viia modulator
02/06/2014US20140038984 Compositions and Methods for the Treatment of Metabolic and Related Disorders
02/05/2014EP2691375A1 Substituted benzimidazoles
02/05/2014EP2691095A2 Imidazolyl amide compounds and uses related thereto
02/05/2014CN103554031A Preparation method of azilsartan intermediate
02/05/2014CN103554030A Novel forms of bendamustine free base
02/05/2014CN103554011A Anthracene containing derivative as well as preparation method and application thereof
01/2014
01/30/2014WO2014017653A1 Capsule compound, negative-ion remover, and negative-ion removal method
01/30/2014WO2013083611A3 Ring-bridged anthraquinone dye for dyeing keratinous fibres
01/30/2014US20140031560 Process for the preparation of bendamustine
01/30/2014US20140031403 Solid Forms of Curcumin
01/29/2014EP2690096A1 Process for preparation of Bendamustine
01/29/2014CN103543618A Resist film remover
01/29/2014CN103543617A Preservative mixture and negative photoresist remover composition
01/29/2014CN103539746A Method for synthesizing 5-difluoromethoxy-2-mercapto-1H-benzimidazole
01/29/2014CN103539726A Novel compound with electron injection and/or electron transport capabilities and organic light-emitting device including the same
01/29/2014CN101743228B Process for preparing telmisartan
01/28/2014US8637676 Dual-acting benzoimidazole antihypertensive agents
01/28/2014CA2535265C Compositions and methods for the treatment of disease associated with trp-p8 expression
01/23/2014WO2014012511A1 N-(3-heteroarylaryl)-4-arylarylcarboxamtdes and analogs as hedgehog pathway inhibitors and use thereof
01/23/2014US20140024692 Methods of Treating Neuropathic Pain with Benzimidazole Derivative Agonists of PPARgamma
01/22/2014EP2687516A1 Inhibitors of C-FMS Kinase
01/22/2014CN103524422A Benzimidazole derivative, and preparation method and purpose thereof
01/21/2014US8633324 Denibulin di-hydrochloride
01/21/2014US8633235 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
01/21/2014US8632914 Triazolium and imidazolium salts and uses thereof
01/16/2014WO2014011831A1 Carbendazim-based catalytic materials
01/16/2014WO2014010611A1 Organic electroluminescence element and electronic apparatus
01/16/2014US20140018534 Benzimidazole Derivatives As PI3 Kinase Inhibitors
01/16/2014US20140018368 Hedgehog antagonists having zinc binding moieties
01/15/2014EP2684468A1 Salty taste enhancer
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 ... 154